Health&Life Co

Health&Life Co Net Tangible Assets

The Net Tangible Assets of Health&Life Co (1781.TWO) as of Nov 7, 2026 is 320.57 M TWD. In the previous year, Net Tangible Assets was 391.03 M TWD — a change of -18.02% (lower).

Net Tangible Assets

320.57 MTWD

YoY

-18.02%

Last updated:

Net Tangible Assets of Health&Life Co is 2025 320.57 M TWD. Net Tangible Assets of Health&Life Co was 2024 391.03 M TWD. It decreases by -18.02% lower compared to the previous year.

The Health&Life Co Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
349.73 M TWD
Jan 1, 2019
265.93 M TWD
Jan 1, 2020
440.82 M TWD
Jan 1, 2021
376.77 M TWD
Jan 1, 2022
365.27 M TWD
Jan 1, 2023
330.90 M TWD
Jan 1, 2024
391.03 M TWD
Jan 1, 2025
320.57 M TWD
The Health&Life Co Net Tangible Assets history
YEARNet Tangible AssetsYoY
320.57 MTWD-18.02%
391.03 MTWD+18.17%
330.90 MTWD-9.41%
365.27 MTWD-3.05%
376.77 MTWD-14.53%
440.82 MTWD+65.77%
265.93 MTWD-23.96%
349.73 MTWD-10.42%
390.39 MTWD-14.64%
457.37 MTWD-16.96%
550.79 MTWD-10.85%
617.80 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Health&Life Co Stock analysis

What does Health&Life Co do? Health&Life Co Ltd generates revenue through the manufacturing and distribution of cardiovascular disease, in-vitro diagnostics, and respiratory care products. The company's primary products include electronic sphygmomanometers such as blood pressure monitors, nebulizers, and blood glucose monitoring systems, which measure and record systolic and diastolic blood pressure and glucose levels. These products are sold domestically in Taiwan and internationally to overseas markets. The firm targets healthcare providers, clinics, and consumers seeking home health monitoring solutions for chronic conditions like hypertension and diabetes. The company's product portfolio focuses on electronic sphygmomanometers, which are essential for daily health monitoring. By offering devices that measure blood pressure and glucose levels, Health&Life Co Ltd caters to patients managing cardiovascular and metabolic diseases. The domestic market in Taiwan serves as a key sales channel, while overseas markets provide additional growth opportunities for the firm's diagnostic and respiratory care products. Health&Life Co Ltd's business model relies on direct sales of medical devices to healthcare institutions and end-users. The firm's electronic sphygmomanometers, including blood pressure monitors and blood glucose systems, are distributed through both domestic and international channels. This approach ensures consistent revenue streams from the ongoing demand for home health monitoring equipment among patients with chronic conditions. Health&Life Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Health&Life Co stock

Net Tangible Assets of Health&Life Co is 320.57 M TWD in 2025.

Net Tangible Assets of Health&Life Co changed from 391.03 M TWD to 320.57 M TWD, representing a -18.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Health&Life Co since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Health&Life Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Health&Life Co

All Key Metrics — Health&Life Co